These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7490682

  • 1. Prostatic intraepithelial neoplasia (PIN). Performance of Bayesian belief network for diagnosis and grading.
    Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW.
    J Pathol; 1995 Oct; 177(2):153-62. PubMed ID: 7490682
    [Abstract] [Full Text] [Related]

  • 2. Subtle changes in benign tissue adjacent to prostate neoplasia detected with a Bayesian belief network.
    Montironi R, Diamanti L, Pomante R, Thompson D, Bartels PH.
    J Pathol; 1997 Aug; 182(4):442-9. PubMed ID: 9306966
    [Abstract] [Full Text] [Related]

  • 3. Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading.
    Mazzucchelli R, Santinelli A, Colanzi P, Streccioni M, Lopez-Beltran A, Scarpelli M, Montironi R.
    Anticancer Res; 2001 Aug; 21(2A):1157-62. PubMed ID: 11396156
    [Abstract] [Full Text] [Related]

  • 4. Prostatic intraepithelial neoplasia. Development of a Bayesian belief network for diagnosis and grading.
    Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW.
    Anal Quant Cytol Histol; 1994 Apr; 16(2):101-12. PubMed ID: 8043157
    [Abstract] [Full Text] [Related]

  • 5. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma.
    Montironi R, Bartels PH, Hamilton PW, Thompson D.
    Hum Pathol; 1996 Apr; 27(4):396-407. PubMed ID: 8617484
    [Abstract] [Full Text] [Related]

  • 6. Case diagnosis as positive identification in prostatic neoplasia.
    Montironi R, Mazzucchelli R, Santinelli A, Hamilton PW, Thompson D, Bartels PH.
    Anal Quant Cytol Histol; 1998 Oct; 20(5):424-36. PubMed ID: 9801761
    [Abstract] [Full Text] [Related]

  • 7. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma.
    Allam CK, Bostwick DG, Hayes JA, Upton MP, Wade GG, Domanowski GF, Klein MA, Boling EA, Stilmant MM.
    Mod Pathol; 1996 Jul; 9(7):742-51. PubMed ID: 8832557
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic distance of high grade prostatic intraepithelial neoplasia from normal prostate and adenocarcinoma.
    Montironi R, Pomante R, Colanzi P, Thompson D, Hamilton PW, Bartels PH.
    J Clin Pathol; 1997 Sep; 50(9):775-82. PubMed ID: 9389981
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of prostatic intraepithelial neoplasia after treatment with a 5-alpha-reductase inhibitor (finasteride). A methodologic approach.
    Montironi R, Pomante R, Diamanti L, Hamilton PW, Thompson D, Bartels PH.
    Anal Quant Cytol Histol; 1996 Dec; 18(6):461-70. PubMed ID: 8978870
    [Abstract] [Full Text] [Related]

  • 11. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F, Epstein JI.
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
    Kronz JD, Shaikh AA, Epstein JI.
    Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
    [Abstract] [Full Text] [Related]

  • 14. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D, Galosi AB, Dell'Atti L, Hanitzsch H, Mario P, Muzzonigro G.
    Scand J Urol Nephrol; 2002 Apr; 36(5):323-9. PubMed ID: 12487735
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R, Jerónimo C, Teixeira MR, Hoque MO, Carvalho AL, Pais I, Ribeiro FR, Oliveira J, Lopes C, Sidransky D.
    Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M, Kraljić I.
    Anticancer Res; 1997 Jan; 17(3A):1531-4. PubMed ID: 9179191
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J.
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.